Medimmune announces phase 2 safety data for anti-RSV antibody and national RSV surveillan...( SAN DIEGO October 4 2007 MedImmune ...),Health
Navigation Links
Medimmune announces phase 2 safety data for anti-RSV antibody and national RSV surveillance results
Date:10/4/2007
SAN DIEGO, October 4, 2007 MedImmune, Inc. today announced results from two important studies presented at the 2007 Infectious Diseases Society of America (IDSA) 45th Annual Meeting adding to the body of knowledge about respiratory syncytial virus (RSV). RSV is a viral pathogen that produces annual outbreaks usually between fall and spring. While RSV typically manifests cold-like symptoms in healthy children, it can prove to be a very serious respiratory illness for premature infants and is the leading cause of respiratory infections for newborns each year. MedImmune has long been committed to developing and improving products for prevention of RSV disease and to enhancing the body of knowledge about RSV epidemiology.
MedImmune continues to forge ahead with its aggressive strategy to help combat RSV disease, said Edward M. Connor, M.D., executive vice president and chief medical officer. We are pleased to present new Phase 2 data at IDSA regarding motavizumab, a key investigational monoclonal antibody (MAb) within our product development portfolio that we are currently preparing for regulatory submission in the United States.
Connor added, We will also present data regarding RSV surveillance at IDSA. These data show regional variability of RSV in the community, particularly in the southernmost United States. We believe that a better understanding of the regional variation in the timing of RSV may help inform decisions about timing of RSV prophylaxis for children at risk for serious RSV disease.
Data pertaining to MedImmunes anti-RSV initiatives that will be presented during the IDSA meeting include:
Safety, Tolerability, and Immunogenicity of Motavizumab in Young Children After a Second Season of RSV Prophylaxis (Poster Presentation #233) Katia G. Abarca, M.D., Infectious Diseases and Molecular Virology Laboratory, Universidad Catlica de Chile, Friday, October 5, 2007; 12:30 2:00 p.m. in Poster Halls G-H
'/>"/>
| Contact: Tor Constantino constantinos@medimmune.com 301-398-5801 Edelman Public Relations Source:Eurekalert |
Related medicine news :
1. PM announces a new health care order for India
2. Ramdoss Announces Introduction of RCH-II
3. Britain Announces Third Transfusion Related Mad Cow Case
4. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
5. Tibet Announces the Dalai Lama’s Tour of South Americ
6. NHS announces further Cost cutting Measures
7. Indian PM Announces Of Setting Up India Study Center At Tashkent
8. PowderMed Announces Needle-Less Flu Vaccine
9. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
10. Australian Government Announces Survey To Tackle Childhood Obesity
11. New Zealand Announces 10-year Plan For Betterment Of Mental Health Care
Post Your Comments:
(Date:11/8/2009)... AARP Praises House Passage of Health Care Reform...n Medicare, improve coverage for all Americans ,...re/ -- ,, SUMMARY: Last night the United Sta...h care reform legislation that would strengthen Me...ance companies that prices millions of Americans o...
(Date:11/8/2009)... WASHINGTON, Nov. 8 Spe...ess conference following the House passage of H.R.... The bill passed by a vote of 220 to 215. Below ...ome of my colleagues just received a call from the...gratulating us on a great victory for the American...
(Date:11/8/2009)... Men’s Health Network (M...ealth risks, especially those linked to exposure t...military service. Bladder cancer is one of those c...s, especially those who once smoked or currently s...gton DC (PRWEB) November 8, 2009 -- Men’s He...
(Date:11/8/2009)... WASHINGTON, Nov. 7 USA...e Health Care for America Act, which will make hea...ance companies accountable and increase access to ...blic option. ,, "Teddy Roosevelt, FDR and Harry...ector Alan Charney. "Today,s vote ranks among our ...
(Date:11/8/2009)... Health Care Vote Shows Who Sides With Working Fa...Pa., Nov. 8 On the heel...epresentatives for a good, balanced health care re...coring of how our state,s U.S. representatives vot...ica Act. ,, The legislation, which passed Satu...
Breaking Medicine News(10 mins):Health News:AARP Pennsylvania Key Vote News Alert 2Health News:AARP Pennsylvania Key Vote News Alert 3Health News:AARP Pennsylvania Key Vote News Alert 4Health News:Veterans' Day Reminder from Men's Health Network: Pay Attention to Bladder Cancer Symptoms and Risk Factors 2Health News:Veterans' Day Reminder from Men's Health Network: Pay Attention to Bladder Cancer Symptoms and Risk Factors 3Health News:Robert Brady (D-PA-1), Chaka Fattah (D-PA-2), Kathy Dahlkemper (D-PA-3), Joe Sestak (D-PA-7), Patrick Murphy (D-PA-8), Christopher Carney (D-PA-10), John Murtha (D-PA-12), Paul Kanjorski (D-PA-11), Allyson Schwartz (D-PA-13), Mike Doyle (D-PA-14) Ge 2[1] AARP Pennsylvania Key Vote News Alert[0] Pelosi Remarks at Press Conference Following Passage of the Affordable Health Care for America Act[0] Veterans' Day Reminder from Men's Health Network: Pay Attention to Bladder Cancer Symptoms and Risk Factors [1] History in the House: Quality, Affordable Health Care for America Is One Step Closer[0] Robert Brady (D-PA-1), Chaka Fattah (D-PA-2), Kathy Dahlkemper (D-PA-3), Joe Sestak (D-PA-7), Patrick Murphy (D-PA-8), Christopher Carney (D-PA-10), John Murtha (D-PA-12), Paul Kanjorski (D-PA-11), Allyson Schwartz (D-PA-13), Mike Doyle (D-PA-14) Ge
...ng to the study conducted by Jennifer D. Thomas, a...e University it was found that alcohol exposure re...These kids develop fetal alcohol spectrum disorder...ssion symptoms, abnormal brain wave activity, fra...
...earch conducted by the scientist at the Monell Che...ism behind the detection of sweet// taste by human... saccharin used in high concentration it losses it...e mouth with water, resulting in the aftertaste ex...
...est figures compiled by National AIDS Control Orga... data collection strategy, have shown that an esti...th HIV. This clearly indicates that the number of ...ed by the deadly virus. It is estimated 38% of fem...
... Sally Field was just short of another milestone, ... had been diagnosed with Osteoporosis.//Osteoporos...inning of the bones which enhances the risk of bon...we are young is faster than bone loss. But this pr...
...ng to Libyan officials the five Bulgarian nurses a...eds of Libyan children with HIV will face a new tr...an foreign ministry said the trial in Libya would ...ere tortured into confessing.
The allegation...
...t Coordinator Jan Vandemoortele and Lt. Gen. Nadee...n and Reconstruction Authority (ERRA) has announce...from the devastating earthquake. The new plan for ...itation system, skill training, teachers training ...
Other Medicine News:Health News:Alcohol Intake During Pregnancy Is Bad For The Baby’s Hear 2Health News:Understanding how humans detect sweet taste 2Health News:HIV/AIDS On The Rise In India 2Health News:Make No Bones About It: Actress Sally, Fields Osteoporosis Like A star! 2(Date:11/6/2009)...Philips Respironics applauds the efforts of the Ce...raise awareness about an important public health i...ease of the first-ever government study to monitor...milestone in quantifying the size and scope of the... leader and sleep therapy manufacturer, Philips Re...
(Date:11/6/2009)...- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX ) ...0, 2009 at 8:30 a.m. EST to discuss the third quar...r the remainder of 2009. Ron Bentsur, Chief Execu...Keryx will announce its financial results for this...he call. ,, In order to participate in the conf...
(Date:11/6/2009)... GeoVax Labs, Inc. (OTC Bulletin Board: GOVX) ("...armaceutical company developing human vaccines for...Virus) and other infectious agents, today announce...vided an operational update. ,, Robert McNally,...ented, "We are pleased with our progress during th...
Breaking Medicine Technology:Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation 2Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2009 Financial Results on Tuesday, November 10, 2009 at 8:30 a.m. EST 2GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 2GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 3GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 4GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 5GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 6GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 7GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 8CeloNova First to Produce Super Sized Embolic Microsphere 60430 1CeloNova First to Produce Super Sized Embolic Microsphere 60430 2Osteotech Announces Third Quarter 2009 Financial Results Release and Conference Call 14668 1Surgery Illness Not Linked to Mental Decline in Seniors 60429 1Surgery Illness Not Linked to Mental Decline in Seniors 60429 2[0] Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation[0] Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2009 Financial Results on Tuesday, November 10, 2009 at 8:30 a.m. EST[0] GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update
...h non-valvular,atrial fibrillation receiving eithe...vestigational oral Factor Xa inhibitor, experience...hose taking warfarin, according to new,Phase II da...he American,Society of Hematology in San Francisco...se II clinical study evaluating an oral Factor Xa ...
...carisbamate, an,investigational compound recently ... partial onset seizures (POS) in patients 16 years...poster sessions of the 32nd Annual,Meeting of the ...o identical placebo-controlled clinical trials,inv...f carisbamate as an,adjunctive treatment for patie...
Other Medicine Technology:New Phase II Data Show Safety of Once-Daily Oral Factor Xa Inhibitor, DU-176b, Comparable to Warfarin in Patients With Non-Valvular Atrial Fibrillation 2New Phase II Data Show Safety of Once-Daily Oral Factor Xa Inhibitor, DU-176b, Comparable to Warfarin in Patients With Non-Valvular Atrial Fibrillation 3New Phase II Data Show Safety of Once-Daily Oral Factor Xa Inhibitor, DU-176b, Comparable to Warfarin in Patients With Non-Valvular Atrial Fibrillation 4New Phase II Data Show Safety of Once-Daily Oral Factor Xa Inhibitor, DU-176b, Comparable to Warfarin in Patients With Non-Valvular Atrial Fibrillation 5Phase III Data Demonstrate Efficacy and Tolerability of Carisbamate as an Adjunctive Therapy for Partial Onset Seizures 2Phase III Data Demonstrate Efficacy and Tolerability of Carisbamate as an Adjunctive Therapy for Partial Onset Seizures 3Phase III Data Demonstrate Efficacy and Tolerability of Carisbamate as an Adjunctive Therapy for Partial Onset Seizures 4Phase III Data Demonstrate Efficacy and Tolerability of Carisbamate as an Adjunctive Therapy for Partial Onset Seizures 5| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |